Your session is about to expire
← Back to Search
Pericapsular Nerve Group Block for Hip Fractures
N/A
Waitlist Available
Led By Michael Halperin
Research Sponsored by Jacobi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 hours.
Awards & highlights
No Placebo-Only Group
Summary
This will be a feasibility study to see if it feasible to perform the Pericapsular Nerve Group Block for hip fractures in the Emergency Department. In addition, we will look at the efficacy of the block in these 10 patients by measuring pain scores at pre-determine time points for 16 hours.
Eligible Conditions
- Trochanteric Fractures
- Acute Pain
- Hip Fracture
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 hours.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 hours.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain Scores
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Peripheral Nerve Block (PENG)Experimental Treatment1 Intervention
Patients will receive the Pericapsular Nerve Group Block.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pericapsular Nerve Group Block
2021
N/A
~90
Find a Location
Who is running the clinical trial?
Jacobi Medical CenterLead Sponsor
22 Previous Clinical Trials
4,341 Total Patients Enrolled
Michael HalperinPrincipal InvestigatorJacobi Medical Center